Show simple item record

dc.contributor.authorDeb, Shoumitro
dc.contributor.authorNancarrow, T
dc.contributor.authorLimbu, B
dc.contributor.authorSheehan, Rory
dc.contributor.authorWilcock, M
dc.contributor.authorBranford, D
dc.contributor.authorCourtenay, K
dc.contributor.authorPerera, B
dc.contributor.authorShankar, Rohit
dc.date.accessioned2021-05-22T19:14:43Z
dc.date.available2021-05-22T19:14:43Z
dc.date.issued2020-09
dc.identifier.issn2056-4724
dc.identifier.issn2056-4724
dc.identifier.othere112
dc.identifier.urihttp://hdl.handle.net/10026.1/17178
dc.description.abstract

<jats:sec id="S2056472420000976_sec_a1" sec-type="other"> <jats:title>Background</jats:title> <jats:p>A high proportion of adults with intellectual disabilities are prescribed off-licence antipsychotics in the absence of a psychiatric illness. The National Health Service in England launched an initiative in 2016, ‘Stopping over-medication of people with a learning disability [intellectual disability], autism or both’ (STOMP), to address this major public health concern.</jats:p> </jats:sec> <jats:sec id="S2056472420000976_sec_a2" sec-type="other"> <jats:title>Aims</jats:title> <jats:p>To gain understanding from UK psychiatrists working with adults with intellectual disabilities on the successes and challenges of withdrawing antipsychotics for challenging behaviours.</jats:p> </jats:sec> <jats:sec id="S2056472420000976_sec_a3" sec-type="methods"> <jats:title>Method</jats:title> <jats:p>An online questionnaire was sent to all UK psychiatrists working in the field of intellectual disability (estimated 225).</jats:p> </jats:sec> <jats:sec id="S2056472420000976_sec_a4" sec-type="results"> <jats:title>Results</jats:title> <jats:p>Half of the 88 respondents stated that they started withdrawing antipsychotics over 5 years ago and 52.3% stated that they are less likely to initiate an antipsychotic since the launch of STOMP. However, since then, 46.6% are prescribing other classes of psychotropic medication instead of antipsychotics for challenging behaviours, most frequently the antidepressants. Complete antipsychotic discontinuation in over 50% of patients treated with antipsychotics was achieved by only 4.5% of respondents (<jats:italic>n</jats:italic> = 4); 11.4% reported deterioration in challenging behaviours in over 50% of patients on withdrawal and the same proportion (11.4%) reported no deterioration. Only 32% of respondents made the diagnosis of psychiatric illness in all their patients themselves. Family and paid carers’ concern, lack of multi-agency and multidisciplinary input and unavailability of non-medical psychosocial intervention are key reported factors hampering the withdrawal attempt.</jats:p> </jats:sec> <jats:sec id="S2056472420000976_sec_a5" sec-type="conclusions"> <jats:title>Conclusions</jats:title> <jats:p>There is an urgent need to develop national guidelines to provide a framework for systematic psychotropic drug reviews and withdrawal where possible.</jats:p> </jats:sec>

dc.format.extente112-
dc.format.mediumElectronic
dc.languageen
dc.language.isoeng
dc.publisherRoyal College of Psychiatrists
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectIntellectual disabilities
dc.subjectantipsychotics
dc.subjectwithdrawal
dc.subjectadults
dc.subjectSTOMP
dc.titleUK psychiatrists’ experience of withdrawal of antipsychotics prescribed for challenging behaviours in adults with intellectual disabilities and/or autism
dc.typejournal-article
dc.typeJournal Article
plymouth.author-urlhttps://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000570177800001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008
plymouth.issue5
plymouth.volume6
plymouth.publication-statusPublished
plymouth.journalBJPsych Open
dc.identifier.doi10.1192/bjo.2020.97
plymouth.organisational-group/Plymouth
plymouth.organisational-group/Plymouth/Faculty of Health
plymouth.organisational-group/Plymouth/Users by role
dc.publisher.placeEngland
dc.identifier.eissn2056-4724
dc.rights.embargoperiodNot known
rioxxterms.versionofrecord10.1192/bjo.2020.97
rioxxterms.licenseref.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
rioxxterms.typeJournal Article/Review


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 International
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International

All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
Atmire NV